Acrivon Therapeutics Inc ACRV

$1.74 +0.02 (1.16%)

Valuation

Market cap
74,136,000
Revenue TTM
$0
Net income TTM
$-77,910,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
168,500
Avg volume
278,028
Day's range
$1.63 – $1.78
Shares out
42,853,000
Stochastic %K
44%
Beta
1.91
Analysts
Strong Sell
Price target
$11.50

Price

Company profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature c...

Show more

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 207 8979
Website
https://acrivon.com
Address
480 Arsenal Way, Suite 100, Watertown, United States

Latest news

Stocktwits

Dani_G_German Oct 27, 2:14 PM
$ACRV 🌈
0 replies
Bullbarbise Oct 21, 8:49 AM
$ACRV
0 replies
TNNStockAnalysisNews Oct 21, 2:06 AM
Stocks Under $15 to Watch Tomorrow, Oct 21, 2026: $BRAI After-Hours +10.6% to $4.75 $ACRV After-Hours +6.9% to $1.92 $CNXU After-Hours +9.7% to $3.28 $AQMS After-Hours +16.2% to $1.65 $EDSA A $27 Million Biotech Moves on Thin After-Hours Volume https://truthsandnews.com/markets/stocks-under-15-to-watch-tomorrow-oct-21-mygn-ino-htz
0 replies
Bullbarbise Oct 19, 11:03 AM
$ACRV stock in the speculator hands for the moment. Hopefully the announce of data release will be communicated in next 2 weeks. Then, we will wait for datas.
0 replies
Dani_G_German Oct 17, 12:35 AM
$ACRV POS
1 replies
Dani_G_German Oct 16, 8:41 PM
$ACRV ugh
0 replies
MonsterMash_17 Oct 15, 3:53 PM
$ACRV CEO said that the upcoming data readout should take place in mid November. We're one month away! Maybe less 🤞.
1 replies
allllll Oct 9, 3:26 PM
$ACRV Near cash value now, what a gem!
0 replies